ESR1 and breast carcinoma: Estrogen receptor ERα has a characteristic ‘mode 3’ C-terminal 14-3-3 binding motif that binds to 14-3-3σ, preventing ERα dimerization and thus inhibits its transcriptional activity which is a driver for breast cancer progression.